Nancy Gray, UAMS BioVentures president and longtime member of the Little Rock Technology Park Authority Board, died June 2 at the age of 66.
Gray was born on Nov. 7, 1954 in Trenton, New Jersey. She was the first member of her family to graduate from college, earning her bachelor’s degree in chemistry from Bucknell University and her doctorate in medicinal chemistry from the University of Illinois.
She was one of only two women in her undergraduate program. Asked to quit when she became pregnant in her fourth year of graduate school, her husband, also a student, offered to stay home with their son instead. Both completed the program.
Over her 30-year career, Gray worked in biomedical industries, holding various executive roles at Monsanto Corp., Vaxinnate Corp., Elan Corp. and the Southern Research Institute.
Her research on central nervous system diseases resulted in three products being accepted for clinical development in five years. She also helped develop antihistamines Allegra and Xyzal. Gray held 31 U.S. patents and authored 23 publications.
Most recently, she led BioVentures at the University of Arkansas Medical Sciences, the technology transfer entity that licenses the technologies created and developed at UAMS. Gray was a professor in the UAMS College of Medicine, Department of Pharmacology and Toxicology as well.
A memorial service was held June 8 at Ruebel Funeral home in Little Rock. A recording of it can be viewed here.